Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of topical sirolimus ointment (UAP006) for facial angiofibromas in pediatric tuberous sclerosis complex
CTR20200203Phase 2Active
- Sponsor
- Aucta Pharmaceuticals, Inc.
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus, sponsored by Aucta Pharmaceuticals, Inc.. Started Dec 2020; status: active.
02
Drugs
sirolimus
Beyond the preview
Go deeper on CTR20200203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200203.